Scribd Logo
Upload

Welcome to Scribd!

  • 130 views

    Stenorol® Crypto - OS - Brochure - EN - v01 - 1020

    Uploaded by

    Drivaila

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Stenorol® Crypto - OS - Brochure - EN - v01 - 1020

    Uploaded by

    Drivaila
    130 views2 pages

    Original Title

    Stenorol® Crypto_OS_Brochure_EN_v01_1020

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    130 views2 pages

    Stenorol® Crypto - OS - Brochure - EN - v01 - 1020

    Uploaded by

    Drivaila

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 2

    Stenorol® CRYPTO

    0.5 mg/ml halofuginone base (as lactate)


    oral solution for calves

    Effective against
    cryptosporidiosis
    in calves
    >
    STENOROL® CRYPTO 0.5 MG/ML HALOFUGINONE BASE (AS LACTATE SALT) ORAL SOLUTION FOR CALVES

    Composition Withdrawal period(s)


    Each ml contains: Meat and offal: 13 days.
    0.50 mg/ml of halofuginone base (as lactate)
    Shelf life and storage
    Target species Shelf-life of the veterinary medicinal product as packaged for

    Stenorol® CRYPTO
    New born calves sale: 12 months.
    Shelf-life after first opening the container: 6 months.
    Indications
    In new born calves: Packaging
    Plastic bottles of 500 ml and 1 L
    Prevention of diarrhoea due to diagnosed Cryptosporidium Not all pack sizes may be marketed
    parvum, in farms with history of cryptosporidiosis. Administration
    should start in the first 24 to 48 hours of age.

    Reduction of diarrhea due to diagnosed Cryptosporidium


    parvum. Administration should start within 24 hours after the
    onset of diarrhoea.

    Dosage and treatment period


    For oral use in calves after feeding.

    2 ml Stenorol® CRYPTO/10 kg BW/per day


    7 consecutive days

    For similar or higher weights, a precise calculation should be


    performed (2 ml/10 kg).
    To ensure a correct dosage, the use of either a syringe or any
    appropriate device for oral administration is necessary.
    The consecutive treatment should be done at the same time
    each day.
    Once the first calf has been treated, all the forthcoming new-
    Contraindications
    born calves must be systematically treated as long as the risk Do not use on an empty stomach.
    for diarrhoea due to C. parvum persists. Do not use in case of diarrhea established for more than 24 hours and in weak animals.
    StenorolCrypto.OS.Calves.Br.EN01.0820/GI

    Special precautions for use in animals: administer after colostrum feeding, or after milk or milk replacer feeding only, using either a syringe or any appropriate device for oral administration. Do
    not use on an empty stomach. For treatment of anorexic calves, the product should be administered in half a liter of an electrolyte solution. The animals should receive enough colostrum according
    to good breeding practice. Special precautions to be taken by the person administering the medicinal product to animals: this product contains halofuginone, which can cause allergic
    reactions in some people. The product may be irritating to the skin and eyes and systemic toxicity cannot be excluded in case of contact with the skin. People with known hypersensitivity (allergy)
    to halofuginone or any of the excipients should administer the veterinary medicinal product with caution. Repetitive contact with the product may lead to skin allergies. Avoid skin, eye or mucosal
    contact with the product. Wash hands after use. Other precautions: none. Adverse reactions (frequency and seriousness): in very rate cases, an increase in the level of diarrhea has been observed
    in treated animals. Use during pregnancy, lactation or lay: not applicable. Interaction with other medicinal products and other forms of interaction: none known. Overdose (symptoms,
    emergency procedures, antidotes), if necessary: symptoms of toxicity may occur at twice the therapeutic dose, it is necessary to apply the recommended dosage strictly. Symptoms of toxicity
    include diarrhea, visible blood in feces, decline in milk consumption, dehydration, apathy and prostration. Should clinical signs of overdosing occur the treatment must be stopped immediately and
    the animal fed milk or milk replacer. Rehydration may be necessary.

    Huvepharma EOOD • 3A Nikolay Haytov Str • 1113 Sofia • Bulgaria • P +359 2 862 5331 • F +359 2 862 5334 • [email protected]
    Huvepharma N.V. • Uitbreidingstraat 80 • 2600 Antwerp • Belgium • P +32 3 288 1849 • F +32 3 289 7845 • [email protected]

    You might also like